Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine - PubMed (original) (raw)

Review

Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine

Jiri Beran. Expert Rev Vaccines. 2007 Dec.

Free article

Abstract

Hepatitis A and B remain serious global public health problems. Monovalent vaccines against hepatitis A and B have been available for many years. Since 1996, licenses have been gradually introduced for different formulations and immunization schedules of the first combined vaccines against both diseases. Twinrix Adult (with conventional and accelerated schedules) is available for the immunization of individuals aged 16 years or older in Europe and 18 years or older the USA. Twinrix Pediatric, with its three-dose schedule, and AmBirix, with its two-dose schedule, are licensed in Europe for ages 1-15 years. These vaccines offer a single injection for satisfactory protection against hepatitis A and B and an excellent safety and reactogenicity profile in comparison with monovalent vaccines. This article focuses on immunogenicity of the vaccines and proposes expert opinion and future directions in this field.

PubMed Disclaimer

Similar articles

• [Ten year's experience with combined hepatitis A and B vaccine].
  Beran J. Beran J. Klin Mikrobiol Infekc Lek. 2008 Feb;14(1):13-4, 16-23. Klin Mikrobiol Infekc Lek. 2008. PMID: 18327736 Review. Czech.
• A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
  Kurugöl Z, Mutlubaş F, Ozacar T. Kurugöl Z, et al. Vaccine. 2005 Apr 22;23(22):2876-80. doi: 10.1016/j.vaccine.2004.11.059. Vaccine. 2005. PMID: 15780736 Clinical Trial.
• Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
  Connor BA, Blatter MM, Beran J, Zou B, Trofa AF. Connor BA, et al. J Travel Med. 2007 Jan-Feb;14(1):9-15. doi: 10.1111/j.1708-8305.2006.00106.x. J Travel Med. 2007. PMID: 17241248 Clinical Trial.
• A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
  Van Damme P, Van Herck K. Van Damme P, et al. Expert Rev Vaccines. 2004 Jun;3(3):249-67. doi: 10.1586/14760584.3.3.249. Expert Rev Vaccines. 2004. PMID: 15176942 Review.
• Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
  Roberton D, Marshall H, Nolan TM, Sokal E, Díez-Domingo J, Flodmark CE, Rombo L, Lewald G, Flor Jde L, Casanovas JM, Verdaguer J, Marés J, Esso DV, Dieussaert I, Stoffel M. Roberton D, et al. Vaccine. 2005 Oct 17;23(43):5099-105. doi: 10.1016/j.vaccine.2005.06.003. Vaccine. 2005. PMID: 16055231 Clinical Trial.

Cited by

• Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses.
  Ahmadi N, Aghasadeghi M, Hamidi-Fard M, Motevalli F, Bahramali G. Ahmadi N, et al. Mol Biotechnol. 2024 Sep;66(9):2362-2380. doi: 10.1007/s12033-023-00867-z. Epub 2023 Sep 16. Mol Biotechnol. 2024. PMID: 37715882
• A case of acute hepatitis A infection in an HIV-positive patient despite complete hepatitis A vaccination.
  Fritzsche C, Loebermann M, Reisinger EC. Fritzsche C, et al. Infection. 2018 Aug;46(4):565-567. doi: 10.1007/s15010-018-1129-1. Epub 2018 Mar 14. Infection. 2018. PMID: 29542052
• Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.
  Lu S, Ren J, Li Q, Jiang Z, Chen Y, Xu K, Ruan B, Yang S, Xie T, Yang L, Li J, Yao J. Lu S, et al. Hum Vaccin Immunother. 2017 Apr 3;13(4):903-908. doi: 10.1080/21645515.2016.1260794. Epub 2016 Dec 1. Hum Vaccin Immunother. 2017. PMID: 27905821 Free PMC article.
• The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.
  Chen Y, Lv H, Gu H, Cui F, Wang F, Yao J, Xia S, Liang X. Chen Y, et al. Hum Vaccin Immunother. 2014;10(2):498-504. doi: 10.4161/hv.26936. Epub 2013 Nov 5. Hum Vaccin Immunother. 2014. PMID: 24192508 Free PMC article.
• Expression of recombinant rotavirus proteins harboring antigenic epitopes of the hepatitis a virus polyprotein in insect cells.
  Than VT, Baek IH, Lee HY, Kim JB, Shon DH, Chung IS, Kim W. Than VT, et al. Biomol Ther (Seoul). 2012 May;20(3):320-5. doi: 10.4062/biomolther.2012.20.3.320. Biomol Ther (Seoul). 2012. PMID: 24130930 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information